Skip to main content
Siegfried Holding AG logo

Siegfried Holding AG — Investor Relations & Filings

Ticker · SFZN ISIN · CH0014284498 LEI · 506700J9QD6IF3937W06 SW Manufacturing
Open in API
Filings indexed 54 across all filing types
Latest filing 2026-05-07 Regulatory Filings
Country CH Switzerland
Listing SW SFZN

About Siegfried Holding AG

https://www.siegfried.ch/?rub=267

Siegfried Holding AG is a global contract development and manufacturing organization (CDMO) serving the pharmaceutical industry. The company's core activities involve the development and manufacturing of active pharmaceutical ingredients (APIs), intermediates, and finished drug products. Its portfolio of finished dosage forms includes tablets, capsules, sterile vials, and ampoules. Siegfried provides an integrated service model, supporting partners from process development through to commercial-scale production. The company is also expanding its capabilities into specialized areas, including ophthalmic drugs and viral vectors for cell and gene therapies.

Recent filings

Filing Released Lang Actions
Siegfried included in Dow Jones Best-in-Class Europe Index
Regulatory Filings
2026-05-07 English
Siegfried included in Dow Jones Best-in-Class Europe Index
Regulatory Filings
2026-05-07 English
Siegfried DINAMIQS receives Swissmedic license for viral vector manufacturing
Regulatory Filings Classification · 80% confidence The document is a corporate media release announcing that Siegfried DINAMIQS received a Swissmedic license for viral vector manufacturing. It is a press release about regulatory approval and does not contain financial results, voting information, dividend details, board changes, or other specific report content. It does not fit into more specific categories like earnings release, annual report, shareholder notifications, M&A, or legal proceedings. Therefore, it falls into the fallback category for general regulatory or corporate announcements: Regulatory Filings (RNS).
2026-04-29 English
Siegfried DINAMIQS receives Swissmedic license for viral vector manufacturing
Regulatory Filings Classification · 90% confidence The document is a press/media release announcing that Siegfried’s CDMO arm obtained a Swissmedic manufacturing license for viral vector production. It contains no financial results, no AGM materials, no management changes, no share transactions, no earnings highlights, and is not a report publication notice. It is a general corporate/regulatory announcement delivered via EQS News, so it falls under the fallback “Regulatory Filings” category (RNS).
2026-04-29 English
Siegfried obtains antitrust clearance for acquisition of three drug substances sites in the US and Australia
M&A Activity Classification · 85% confidence The document is an ad hoc media release pursuant to Art. 53 Listing Rules announcing that Siegfried has obtained antitrust clearance and will close its previously announced acquisition of three drug substance sites. This is a corporate transaction announcement concerning an acquisition (M&A) rather than a financing update, management change, or regular report. Therefore, it fits the M&A Activity category (Code: TAR).
2026-04-24 English
Siegfried obtains antitrust clearance for acquisition of three drug substances sites in the US and Australia
M&A Activity Classification · 92% confidence The document is an ad hoc announcement under Listing Rules announcing the satisfaction of closing conditions and antitrust clearance for the acquisition of three manufacturing sites in the US and Australia. This clearly describes an M&A transaction announcement. It is not a financial report, earnings release, or board change notice, but specifically relates to an acquisition. Therefore, it falls under M&A Activity (Code: TAR).
2026-04-24 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.